Advertisement

Topics

Barr Pharmaceuticals, Inc Company Profile

11:18 EDT 22nd September 2017 | BioPortfolio

Barr Pharmaceuticals, Inc. is a Delaware holding company whose principal subsidiaries, Barr Laboratories, Inc. and Duramed Pharmaceuticals, Inc., develop, manufacture and market generic and proprietary pharmaceutical products, respectively. The Company’s generic products are marketed under the “Barr” label, and proprietary products are marketed under the “Duramed” label.

Location

223 Quaker Road
Pomona
10970
United States of America

Contact

Phone: 845-362-1100 or 800-222-0190
Fax: 845-362-2774
Email: CustomerService@barrlabs.com


News Articles [1271 Associated News Articles listed on BioPortfolio]

Epstein-Barr Virus Increases Risk of MS

While being infected at a young age with Epstein-Barr virus generally causes few, if any, symptoms, delayed exposure into adolescence...

Epstein-Barr virus steers B-cells to hide in plain sight

Viruses are notorious for taking over their host's operations and using them to their own advantage. But few human viruses make themselves quite as cozy as the Epstein-Barr virus, which can be found ...

Deals this week: Pivot Pharmaceuticals, Innovation Pharmaceuticals, Portola Pharmaceuticals

Pivot Pharmaceuticals plans to acquire the worldwide rights to Altum Pharmaceuticals’ BiPhasix Transdermal drug delivery technology.

Inotek Pharmaceuticals announces merger deal with Rocket Pharmaceuticals

Inotek Pharmaceuticals announced that it has entered into a definitive merger agreement with US-based gene therapy company Rocket Pharmaceuticals.

Epstein-Barr Virus and Multiple Sclerosis Risk Among Different Races/Ethnicities

This U.S. study found EBV exposure to be associated with increased MS risk.

Mono May Boost MS Risk (CME/CE)

(MedPage Today) -- Epstein-Barr infection tied to higher MS risk in blacks, whites, Hispanics

Easton Pharmaceuticals Announces That Its Partner Windsor Pharmaceuticals Has Received Regulatory Approvals For Products VS-Sense and AL-Sense For Central America and The Caribbean

TORONTO, ON -- (Marketwired) -- 09/12/17 -- Easton Pharmaceuticals Inc. (OTC PINK: EAPH) and its JV partner BMV Medica SA de CV announces that its distributor Windsor Pharmaceuticals SA has receiv...

Early Detection of Nasopharyngeal Cancer With EBV DNA

Screening for Epstein-Barr virus DNA in plasma samples identified nasopharyngeal carcinoma significantly earlier compared with historical controls. Medscape Medical News

PubMed Articles [302 Associated PubMed Articles listed on BioPortfolio]

Plasma exchange for Guillain-Barré syndrome.

Guillain-Barré syndrome (GBS) is an acute paralysing disease caused by peripheral nerve inflammation. This is an update of a review first published in 2001 and last updated in 2012.

Guillain-Barré Syndrome, variants & forms fruste: Reclassification with new criteria.

This study aimed to evaluate the clinical and electrophysiological characteristics of various distinctive classical and localised Guillain-Barré syndrome (GBS) subtypes.

Guillain-Barré-like axonal polyneuropathy associated with Toscana virus infection: A case report.

Numerous cases of post-infectious Guillain-Barré syndrome (GBS) have been reported in the literature. Toscana virus (TOSV) is an arthropod-borne emerging pathogen in the Mediterranean area.

Announcing the 2017 Pharmaceuticals Travel Award for Young Post-Doctoral Researchers.

Last year, for the first time in its history, our Journal was able to offer a travel grant of 800 CHF to a young researcher in the field of medicinal chemistry.

Motor nerve excitability after childhood Guillain-Barré syndrome.

To determine the residual motor nerve dysfunction after pediatric Guillain-Barré syndrome (GBS).

Clinical Trials [295 Associated Clinical Trials listed on BioPortfolio]

Immunotherapy for Lymphoproliferative Diseases Associated With Epstein-Barr Virus in Patients Who Have Undergone Organ Transplants

RATIONALE: Donor lymphocytes that have been exposed to Epstein-Barr virus may be able to help the body kill cancers associated with this virus. PURPOSE: Phase I trial to study the effecti...

Phenylbutyrate and Valganciclovir in Treating Patients With Relapsed or Refractory Epstein-Barr Virus-Positive Cancer

RATIONALE: The Epstein-Barr virus can cause cancer and lymphoproliferative disorders. Valganciclovir is an antiviral drug that acts against the Epstein-Barr virus. Phenylbutyrate may make ...

Biological Therapy in Treating Patients With Lymphoma, Lymphoproliferative Disease, or Malignancies

RATIONALE: Some types of lymphoma or lymphoproliferative disease are associated with Epstein-Barr virus. White blood cells from donors who are immune to Epstein-Barr virus may be an effect...

Peripheral Blood Lymphocyte Therapy to Prevent Lymphoproliferative Disorders Caused by Epstein-Barr Virus in Patients Who Have Undergone Transplantation

RATIONALE: Peripheral blood lymphocyte therapy may be effective in the treatment and prevention of Epstein-Barr virus infection following transplantation. PURPOSE: Phase II trial to study...

T-Lymphocytes in Treating Patients With Epstein-Barr Virus-Positive Nasopharyngeal Cancer

RATIONALE: T lymphocytes treated in the laboratory may help the body build an effective immune response to kill tumor cells in patients with Epstein-Barr virus infection. PURPOSE: This ph...

Companies [1291 Associated Companies listed on BioPortfolio]

Barr Pharmaceuticals, Inc

Barr Pharmaceuticals, Inc. is a Delaware holding company whose principal subsidiaries, Barr Laboratories, Inc. and Duramed Pharmaceuticals, Inc., develop, manufacture and market generic and proprietar...

Barr Laboratories Incorporated

Barr Laboratories, Inc. is an established pharmaceutical company engaged in the development, manufacture and marketing of generic and proprietary prescription pharmaceuticals. The Company was founded ...

Barr Pharmaceuticals, Inc.

W.M. Barr

Headquartered in Memphis, TN, W.M. Barr, is part of Barr Brands International, and is a leader in specialty cleaning and home improvement products. Among its many brands are DampR...

Barr Associates, Inc

Barr Associates is the world's largest independent manufacturer of precision thin film coatings and optical filters. We have an unmatched heritage in the optical filter and coating business with a str...

More Information about "Barr Pharmaceuticals, Inc" on BioPortfolio

We have published hundreds of Barr Pharmaceuticals, Inc news stories on BioPortfolio along with dozens of Barr Pharmaceuticals, Inc Clinical Trials and PubMed Articles about Barr Pharmaceuticals, Inc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Barr Pharmaceuticals, Inc Companies in our database. You can also find out about relevant Barr Pharmaceuticals, Inc Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Generics Drugs
A generic drug (generic drugs, short: generics) is a drug defined as "a drug product that is comparable to brand/reference listed drug product in dosage form, strength, route of administration, quality and performance characteristics, and intended u...


Corporate Database Quicklinks



Searches Linking to this Company Record